Cargando…
Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845684/ https://www.ncbi.nlm.nih.gov/pubmed/36300328 http://dx.doi.org/10.3350/cmh.2022.0326 |
| _version_ | 1784870963369738240 |
|---|---|
| author | Liu, Yuanbin Chen, Mingkai |
| author_facet | Liu, Yuanbin Chen, Mingkai |
| author_sort | Liu, Yuanbin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9845684 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Association for the Study of the Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98456842023-01-31 Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” Liu, Yuanbin Chen, Mingkai Clin Mol Hepatol Letter to the Editor The Korean Association for the Study of the Liver 2023-01 2022-10-27 /pmc/articles/PMC9845684/ /pubmed/36300328 http://dx.doi.org/10.3350/cmh.2022.0326 Text en Copyright © 2023 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Liu, Yuanbin Chen, Mingkai Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” |
| title | Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” |
| title_full | Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” |
| title_fullStr | Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” |
| title_full_unstemmed | Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” |
| title_short | Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways” |
| title_sort | letter regarding “auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via nrf2 and nf-κb signaling pathways” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845684/ https://www.ncbi.nlm.nih.gov/pubmed/36300328 http://dx.doi.org/10.3350/cmh.2022.0326 |
| work_keys_str_mv | AT liuyuanbin letterregardingauranofinattenuateshepaticsteatosisandfibrosisinnonalcoholicfattyliverdiseasevianrf2andnfkbsignalingpathways AT chenmingkai letterregardingauranofinattenuateshepaticsteatosisandfibrosisinnonalcoholicfattyliverdiseasevianrf2andnfkbsignalingpathways |